Skip to Content

Kabiven FDA Approval History

FDA Approved: Yes (First approved August 25, 2014)
Brand name: Kabiven
Generic name: amino acids, electrolytes, dextrose and lipid
Dosage form: Injectable Emulsion
Company: Fresenius Kabi USA, LLC
Treatment for: Parenteral Nutrition

Kabiven (amino acids, electrolytes, dextrose and lipid injectable emulsion) is indicated as a source of calories, protein, electrolytes and essential fatty acids for adult patients requiring parenteral nutrition.

Development Timeline for Kabiven

DateArticle
Aug 27, 2014ApprovalFresenius Kabi Receives FDA Approval for Kabiven and Perikabiven

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.